Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.

Müller-Jensen, Leonie; Zierold, Sarah; Versluis, Judith M; Boehmerle, Wolfgang; Huehnchen, Petra; Endres, Matthias; Mohr, Raphael; Compter, Annette; Blank, Christian U; Hagenacker, Tim; Meier, Friedegund; Reinhardt, Lydia; Gesierich, Anja; Salzmann, Martin; Hassel, Jessica C; Ugurel, Selma; Zimmer, Lisa; Banks, Patricia; Spain, Lavinia; Soon, Jennifer A; Enokida, Tomohiro; Tahara, Makoto; Kähler, Katharina C; Seggewiss-Bernhardt, Ruth; Harvey, Catriona; Long, Georgina V; Schöberl, Florian; von Baumgarten, Louisa; Hundsberger, Thomas; Schlaak, Max; French, Lars E; Knauss, Samuel; Heinzerling, Lucie M

Müller-Jensen, Leonie; Zierold, Sarah; Versluis, Judith M; Boehmerle, Wolfgang; Huehnchen, Petra; Endres, Matthias; Mohr, Raphael; Compter, Annette; Blank, Christian U; Hagenacker, Tim; Meier, Friedegund; Reinhardt, Lydia; Gesierich, Anja; Salzmann, Martin; Hassel, Jessica C; Ugurel, Selma; Zimmer, Lisa; Banks, Patricia; Spain, Lavinia; Soon, Jennifer A; Enokida, Tomohiro; Tahara, Makoto; Kähler, Katharina C; Seggewiss-Bernhardt, Ruth; Harvey, Catriona; Long, Georgina V; Schöberl, Florian; von Baumgarten, Louisa; Hundsberger, Thomas; Schlaak, Max; French, Lars E; Knauss, Samuel; Heinzerling, Lucie M.

Afiliação

Müller-Jensen L; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt- Universität zu Berlin, Charitéplatz 1, Berlin 10117, Germany.
Zierold S; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.
Versluis JM; SERIO Side Effects Registry Immunooncology, Germany.
Boehmerle W; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilian Universität Munich, Frauenlobstr. 9-11, München 80337, Germany.
Huehnchen P; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Endres M; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt- Universität zu Berlin, Charitéplatz 1, Berlin 10117, Germany.
Mohr R; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt- Universität zu Berlin, Charitéplatz 1, Berlin 10117, Germany.
Compter A; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.
Blank CU; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt- Universität zu Berlin, Charitéplatz 1, Berlin 10117, Germany.
Hagenacker T; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.
Meier F; NeuroCure Cluster of Excellence, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
Reinhardt L; Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin 10117, Germany.
Gesierich A; German Center for Neurodegenerative Diseases (DZNE), Partner Site Berlin, Germany.
Salzmann M; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Hassel JC; Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt- Universität zu Berlin, , Augustenburger Platz 1, Berlin 13353, Germany.
Ugurel S; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Zimmer L; Department of Medical Oncology, Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Banks P; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, Hufelandstr. 55, Essen 45147, Germany.
Spain L; Department of Dermatology, Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases, TU Dresden, University Hospital Carl Gustav Carus, Dresden, Germany.
Soon JA; Department of Dermatology, Skin Cancer Center at the University Cancer Center Dresden and National Center for Tumor Diseases, TU Dresden, University Hospital Carl Gustav Carus, Dresden, Germany.
Enokida T; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
Tahara M; Department of Dermatology and National Center for Tumor Diseases (NCT), Skin Cancer Center, University Hospital Heidelberg, Heidelberg, Germany.
Kähler KC; Department of Dermatology and National Center for Tumor Diseases (NCT), Skin Cancer Center, University Hospital Heidelberg, Heidelberg, Germany.
Seggewiss-Bernhardt R; Department of Dermatology, Venerology und Allergology, University Hospital Essen, Essen, Germany.
Harvey C; Department of Dermatology, Venerology und Allergology, University Hospital Essen, Essen, Germany.
Long GV; Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Australia.
Schöberl F; Medical Oncology Department, Peter MacCallum Cancer Center, Melbourne, Australia.
von Baumgarten L; Medical Oncology Department, Peter MacCallum Cancer Center, Melbourne, Australia.
Hundsberger T; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
Schlaak M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
French LE; Department of Dermatology, Venerology and Allergology, University of Schleswig-Holstein Hospital, Campus Kiel, Germany.
Knauss S; Department of Hematology and Oncology, Sozialstiftung Bamberg, Bamberg, Germany.
Heinzerling LM; Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.